{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:22:05Z","timestamp":1787851325413,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.esmoop.2026.108252","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:46:59Z","timestamp":1784227619000},"page":"108252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monoallelic BRCA1\/2 variants in pediatric, adolescent, and young adult patients with central nervous system tumors"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8730-0094","authenticated-orcid":false,"given":"S.","family":"Cipri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Agolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.D.","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cacchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Megaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Carai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"Colafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-4270","authenticated-orcid":false,"given":"L.","family":"Boccuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mastronuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.esmoop.2026.108252_bib1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1200\/JCO.23.01747","article-title":"Adolescents and young adults with cancer: CNS tumors","volume":"42","author":"Wu","year":"2024","journal-title":"J Clin Oncol"},{"issue":"suppl 4","key":"10.1016\/j.esmoop.2026.108252_bib2","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaf194","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2018-2022","volume":"27","author":"Price","year":"2025","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108252_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108252_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00401-020-02130-0","article-title":"An update on the central nervous system manifestations of familial tumor predisposition syndromes","volume":"139","author":"Solomon","year":"2020","journal-title":"Acta Neuropathol (Berl)"},{"issue":"22","key":"10.1016\/j.esmoop.2026.108252_bib5","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.3390\/cancers15225430","article-title":"Advances in early breast cancer risk profiling: from histopathology to molecular technologies","volume":"15","author":"Pescia","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108252_bib6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/cancers17091432","article-title":"Germline DNA repair gene mutations and clonal hematopoiesis (CH) in 24,849 patients with BRCA-associated cancers","volume":"17","author":"Marshall","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108252_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf395","article-title":"Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study","volume":"30","author":"Incorvaia","year":"2025","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108252_bib8","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.ajhg.2025.10.007","article-title":"BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes","volume":"112","author":"Johnatty","year":"2025","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108252_bib9","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/ijc.70097","article-title":"Germline variants observed in pediatric cancer patients related to hereditary breast and ovarian cancer in adults","volume":"157","author":"Daugs","year":"2025","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108252_bib10","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00381-023-06267-7","article-title":"Germline BRCA2 pathogenic variants in pediatric ganglioglioma: case report and review of the literature","volume":"40","author":"Gupta","year":"2024","journal-title":"Childs Nerv Syst"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108252_bib11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/jnci\/djac151","article-title":"Heterozygous BRCA1 and BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer","volume":"114","author":"Kratz","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108252_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30643","article-title":"Loss of heterozygosity does not occur in BRCA1\/2 mutant pediatric solid and central nervous system tumors","volume":"70","author":"Groves","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108252_bib13","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/neuonc\/noaf061","article-title":"Germline analysis of an international cohort of pediatric diffuse midline glioma patients","volume":"27","author":"Mateos","year":"2025","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108252_bib14","article-title":"Frequency of pathogenic germline variants in cancer-susceptibility genes in the Childhood Cancer Survivor Study","volume":"5","author":"Kim","year":"2021","journal-title":"JNCI Cancer Spectr"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108252_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108252_bib17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/humu.24309","article-title":"Variant interpretation using population databases: lessons from gnomAD","volume":"43","author":"Gudmundsson","year":"2022","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108252_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10549-017-4181-0","article-title":"Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients","volume":"163","author":"Crawford","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108252_bib22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/humu.23842","article-title":"The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries","volume":"40","author":"Laitman","year":"2019","journal-title":"Hum Mutat"},{"key":"10.1016\/j.esmoop.2026.108252_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40364-015-0038-z","article-title":"Characterization of medulloblastoma in Fanconi anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup","volume":"3","author":"Miele","year":"2015","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108252_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jmoldx.2017.09.005","article-title":"Evaluation of a next-generation sequencing assay for BRCA1 and BRCA2 mutation detection","volume":"20","author":"Capone","year":"2018","journal-title":"J Mol Diagn"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108252_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/cancers11020132","article-title":"Causes for frequent pathogenic BRCA1 variants include low penetrance in fertile ages, recurrent de-novo mutations and genetic drift","volume":"11","author":"M\u00f8ller","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108252_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/jnci\/djae306","article-title":"Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers","volume":"117","author":"Li","year":"2025","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108252_bib27","doi-asserted-by":"crossref","first-page":"8006","DOI":"10.1038\/s41467-023-43730-0","article-title":"Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children\u2019s Oncology Group AREN18B5-Q","volume":"14","author":"Murphy","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.esmoop.2026.108252_bib28","article-title":"A novel germline compound heterozygous mutation of BRCA2 gene associated with familial peripheral neuroblastic tumors in two siblings","volume":"12","author":"Yang","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.esmoop.2026.108252_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104395","article-title":"Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma","volume":"87","author":"Bonfiglio","year":"2023","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108252_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111073","article-title":"Genetic and clinical characteristics of genetic tumor syndromes in the central nervous system cancers: implications for clinical practice","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108252_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3174\/ajnr.A8039","article-title":"Newly recognized genetic tumor syndromes of the CNS in the 5th WHO classification: imaging overview with genetic updates","volume":"45","author":"Agarwal","year":"2024","journal-title":"AJNR Am J Neuroradiol"},{"issue":"suppl 4","key":"10.1016\/j.esmoop.2026.108252_bib32","first-page":"0","article-title":"LGG-24. Pediatric ganglioglioma with germline BRCA2 mutation","volume":"26","author":"Gupta","year":"2024","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108252_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12883-016-0632-1","article-title":"Anomalous vascularization in a Wnt medulloblastoma: a case report","volume":"16","author":"Di Giannatale","year":"2016","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108252_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-024-01547-4","article-title":"Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study","volume":"17","author":"Kastellan","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108252_bib35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.annonc.2025.11.004","article-title":"Association between type and location of germline BRCA1\/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study","volume":"37","author":"Toss","year":"2026","journal-title":"Ann Oncol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926021940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926021940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:35:00Z","timestamp":1787848500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926021940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2059702926021940"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108252","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoallelic BRCA1\/2 variants in pediatric, adolescent, and young adult patients with central nervous system tumors","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108252"}}